Intrepid Financial Planning Group LLC Actinium Pharmaceuticals, Inc. Transaction History
Intrepid Financial Planning Group LLC
- $234 Million
- Q4 2024
A detailed history of Intrepid Financial Planning Group LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Intrepid Financial Planning Group LLC holds 14,000 shares of ATNM stock, worth $18,340. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,000
Previous 19,000
26.32%
Holding current value
$18,340
Previous $35,000
51.43%
% of portfolio
0.01%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding ATNM
# of Institutions
70Shares Held
7.94MCall Options Held
59.6KPut Options Held
4.8K-
Black Rock Inc. New York, NY1.88MShares$2.46 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.62MShares$2.12 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$901,0870.0% of portfolio
-
State Street Corp Boston, MA621KShares$813,6080.0% of portfolio
-
Acadian Asset Management LLC Boston, MA499KShares$654,0300.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $33M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...